Literature DB >> 25242482

Synthetic fermentation of bioactive non-ribosomal peptides without organisms, enzymes or reagents.

Yi-Lin Huang1, Jeffrey W Bode2.   

Abstract

Microbial fermentation can rapidly provide potent compounds that can be easily screened for biological activity, and the active components can be isolated. Its success in drug discovery has inspired extensive efforts to modulate and control the products. In this Article, we document a 'synthetic fermentation' of bioactive, unnatural peptides 'grown' from small building blocks in water using amide-forming ligations. No organisms, enzymes or reagents are needed. The sequences, structures and compositions of the products can be modulated by adjusting the building blocks and conditions. No specialized knowledge of organic chemistry or handling of toxic material is required to produce complex organic molecules. The 'fermentations' can be conducted in arrays and screened for biological activity without isolation or workup. As a proof-of-concept, about 6,000 unnatural peptides were produced from just 23 building blocks, from which a hepatitis C virus NS3/4A protease inhibitor with a half-maximum inhibitory concentration of 1.0 μM was identified and characterized.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25242482     DOI: 10.1038/nchem.2048

Source DB:  PubMed          Journal:  Nat Chem        ISSN: 1755-4330            Impact factor:   24.427


  43 in total

1.  Modular Peptide Synthetases Involved in Nonribosomal Peptide Synthesis.

Authors:  Mohamed A. Marahiel; Torsten Stachelhaus; Henning D. Mootz
Journal:  Chem Rev       Date:  1997-11-10       Impact factor: 60.622

Review 2.  Manufacturing molecules through metabolic engineering.

Authors:  Jay D Keasling
Journal:  Science       Date:  2010-12-03       Impact factor: 47.728

3.  AMIDE FORMATION BY DECARBOXYLATIVE CONDENSATION OF HYDROXYLAMINES AND α-KETOACIDS: N-[(1S)-1 PHENYLETHYL]-BENZENEACETAMIDE.

Authors:  Lei Ju; Jeffrey W Bode; Tatsuya Toma; Tohru Fukuyama
Journal:  Organic Synth       Date:  2010-12-01

Review 4.  Contributions of microorganisms to industrial biology.

Authors:  Arnold L Demain; Jose L Adrio
Journal:  Mol Biotechnol       Date:  2008-01       Impact factor: 2.695

Review 5.  Total biosynthesis: in vitro reconstitution of polyketide and nonribosomal peptide pathways.

Authors:  Elizabeth S Sattely; Michael A Fischbach; Christopher T Walsh
Journal:  Nat Prod Rep       Date:  2008-05-23       Impact factor: 13.423

Review 6.  Genomic basis for natural product biosynthetic diversity in the actinomycetes.

Authors:  Markus Nett; Haruo Ikeda; Bradley S Moore
Journal:  Nat Prod Rep       Date:  2009-09-01       Impact factor: 13.423

7.  Synthesis of acyltrifluoroborates.

Authors:  Aaron M Dumas; Jeffrey W Bode
Journal:  Org Lett       Date:  2012-04-04       Impact factor: 6.005

8.  Heterologous expression of a myxobacterial natural products assembly line in pseudomonads via red/ET recombineering.

Authors:  Silke C Wenzel; Frank Gross; Youming Zhang; Jun Fu; A Francis Stewart; Rolf Müller
Journal:  Chem Biol       Date:  2005-03

9.  Control of directionality in nonribosomal peptide synthesis: role of the condensation domain in preventing misinitiation and timing of epimerization.

Authors:  U Linne; M A Marahiel
Journal:  Biochemistry       Date:  2000-08-29       Impact factor: 3.162

10.  Discovery of (1R,5S)-N-[3-amino-1-(cyclobutylmethyl)-2,3-dioxopropyl]- 3-[2(S)-[[[(1,1-dimethylethyl)amino]carbonyl]amino]-3,3-dimethyl-1-oxobutyl]- 6,6-dimethyl-3-azabicyclo[3.1.0]hexan-2(S)-carboxamide (SCH 503034), a selective, potent, orally bioavailable hepatitis C virus NS3 protease inhibitor: a potential therapeutic agent for the treatment of hepatitis C infection.

Authors:  Srikanth Venkatraman; Stéphane L Bogen; Ashok Arasappan; Frank Bennett; Kevin Chen; Edwin Jao; Yi-Tsung Liu; Raymond Lovey; Siska Hendrata; Yuhua Huang; Weidong Pan; Tejal Parekh; Patrick Pinto; Veljko Popov; Russel Pike; Sumei Ruan; Bama Santhanam; Bancha Vibulbhan; Wanli Wu; Weiying Yang; Jianshe Kong; Xiang Liang; Jesse Wong; Rong Liu; Nancy Butkiewicz; Robert Chase; Andrea Hart; Sony Agrawal; Paul Ingravallo; John Pichardo; Rong Kong; Bahige Baroudy; Bruce Malcolm; Zhuyan Guo; Andrew Prongay; Vincent Madison; Lisa Broske; Xiaoming Cui; Kuo-Chi Cheng; Yunsheng Hsieh; Jean-Marc Brisson; Danial Prelusky; Walter Korfmacher; Ronald White; Susan Bogdanowich-Knipp; Anastasia Pavlovsky; Prudence Bradley; Anil K Saksena; Ashit Ganguly; John Piwinski; Viyyoor Girijavallabhan; F George Njoroge
Journal:  J Med Chem       Date:  2006-10-05       Impact factor: 7.446

View more
  6 in total

1.  Drug discovery: Combichem all over again.

Authors:  Derek B Lowe
Journal:  Nat Chem       Date:  2014-10       Impact factor: 24.427

Review 2.  Combinatorial chemistry in drug discovery.

Authors:  Ruiwu Liu; Xiaocen Li; Kit S Lam
Journal:  Curr Opin Chem Biol       Date:  2017-05-08       Impact factor: 8.822

3.  Activity-Directed Synthesis of Inhibitors of the p53/hDM2 Protein-Protein Interaction.

Authors:  Adam I Green; Fruzsina Hobor; Christopher P Tinworth; Stuart Warriner; Andrew J Wilson; Adam Nelson
Journal:  Chemistry       Date:  2020-08-04       Impact factor: 5.236

4.  Activity-Directed Synthesis with Intermolecular Reactions: Development of a Fragment into a Range of Androgen Receptor Agonists.

Authors:  George Karageorgis; Mark Dow; Anthony Aimon; Stuart Warriner; Adam Nelson
Journal:  Angew Chem Int Ed Engl       Date:  2015-09-11       Impact factor: 15.336

5.  Synthetic fermentation of β-peptide macrocycles by thiadiazole-forming ring-closing reactions.

Authors:  Jonathan G Hubert; Iain A Stepek; Hidetoshi Noda; Jeffrey W Bode
Journal:  Chem Sci       Date:  2018-01-08       Impact factor: 9.825

6.  Activity-Directed Synthesis: A Flexible Approach for Lead Generation.

Authors:  George Karageorgis; Samuel Liver; Adam Nelson
Journal:  ChemMedChem       Date:  2020-09-04       Impact factor: 3.466

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.